DH Cracks Down on Illegal Anti-Obesity Drug Sales in Hong Kong, Arrests Five Suspects

DH clamps down on trafficking in dangerous drug and illegal sale or possession of unregistered anti-obesity medicine

In light of the fact that there are people illegally selling or possessing unregistered anti-obesity medicine that is Part 1 poison and prescription drug under the Pharmacy and Poisons Ordinance (Cap. 138), the Department of Health (DH) announced today (April 20) that it has stepped up inspection and enforcement efforts across Hong Kong in recent days. In collaboration with the Police, five men suspected of violating drug-related laws were arrested and a large quantity of unregistered drugs were seized. These included unregistered anti-obesity drugs labelled in Japanese as containing tirzepatide.

The DH carried out an enforcement operation with the Police last Friday (April 17) to search a registered pharmacy in Sha Tin District. Over 400 tablets of the dangerous drug clonazepam, 20 items of unregistered pharmaceutical products which included six boxes of anunregistered anti-obesity medicine labelled in Japanese as containing tirzepatide, and over 30 other items of controlled medicines, including over 2 700 tablets of zolpidem, were seized. During the operation, four men aged between 25 and 55 were arrested on suspicion of contravention of drug-related offences, including trafficking in a dangerous drug, illegal possession of unregistered pharmaceutical products, and failing to store Part 1 poisons in a locked receptacle, etc.

Earlier today, the DH carried out another enforcement operation with the Police against a registered pharmacy in Jordan, arresting a 36-year-old man. He is suspected of illegally selling an anti-obesity medicine (a Part 1 poison containing tirzepatide as indicated in Japanese on the product labels) and an unregistered pharmaceutical product, as well as failing to store Part 1 poisons in a locked receptable. The operation also resulted in the seizure of 13 boxes of unregistered anti-obesity medicine labelled in Japanese as containing tirzepatide.

The DH investigations continue.

Tirzepatide is used for the treatment of obesity, and its side effects include vomiting, nausea and diarrhoea. Medicines containing tirzepatide, zolpidem, and clonazepam are Part 1 poisons and prescription drugs under the Pharmacy and Poisons Ordinance , should be used under a doctor's direction and must be supplied on the premises of a registered pharmacy under the supervision of a registered pharmacist upon a doctor's prescription. Furthermore, clonazepam is a dangerous drug regulated under the Dangerous Drugs Ordinance (Cap. 134).

The DH emphasised that it has an established mechanism to monitor the sale of pharmaceutical products in the market (including the Internet). If the DH detects any suspected illegal sale or possession of pharmaceutical products, Part 1 poisons or dangerous drugs, the DH will promptly investigate, and, if necessary, refer the case to other law enforcement agencies to follow up, or conduct joint operations with other law enforcement agencies, and any irregularities so found will be dealt with in accordance with the law. Illegal sale or possession of unregistered pharmaceutical products or Part 1 poisons and failing to store Part 1 poisons in locked receptacles are criminal offences under the Pharmacy and Poisons Ordinance (Cap. 138), which upon conviction, are subject to a fine of up to $100,000 and an imprisonment for two years. Furthermore, any person who traffics in a dangerous drug shall be liable upon conviction to a fine of $5,000,000 andimprisonment for life under the Dangerous Drugs Ordinance.

According to the Pharmacy and Poisons Ordinance (Cap. 138), all pharmaceutical products must be registered with the Pharmacy and Poisons Board of Hong Kong before they can be legally sold in the market. The DH reminded the public that all registered pharmaceutical products should carry a Hong Kong registration number on the package in the format of "HK-XXXXX". The safety, quality and efficacy of unregistered pharmaceutical products are not guaranteed.

The DH reminded the public that weight control should be achieved through a balanced diet and appropriate exercise. The public should consult healthcare professionals before consuming any medication for weight control. They may visit the website of the Drug Office of the DH for "Health message on overweight problem and slimming products" and "Slimming products with undeclared Western drug ingredients" for information.

The Department of Health (DH) has stepped up inspection and enforcement efforts across Hong Kong in recent days, arresting five men suspected of violating drug-related laws and seizing a large quantity of unregistered drugs in collaboration with the Police. Photo shows four DH staff members carrying out an enforcement operation at a registered pharmacy in Jordan. Source: HKSAR Government Press Releases

The Department of Health has stepped up inspection and enforcement efforts across Hong Kong in recent days, arresting five men suspected of violating drug-related laws and seizing a large quantity of unregistered drugs in collaboration with the Police. Photo shows seized unregistered anti-obesity drugs labelled in Japanese as containing tirzepatide. Source: HKSAR Government Press Releases

HKSAR and Mainland sign new arrangement on mutual service of judicial documents in civil and commercial proceedings

The Secretary for Justice, Mr Paul Lam, SC, and Vice-president of the Supreme People's Court (SPC) Mr Mao Zhonghua signed the Arrangement on Mutual Service of Judicial Documents in Civil and Commercial Proceedings between the Mainland and the Hong Kong Special Administrative Region(New Arrangement) yesterday (April 20), enhancing the mechanism for mutual service of judicial documents in civil and commercial proceedings between the two places.

Over the 27 years since the implementation of the existing Arrangement for Mutual Service of Judicial Documents in Civil and Commercial Proceedings between the Mainland and Hong Kong Courts (Existing Arrangement), the volume of requests for mutual service of judicial documents between the courts of the two places has surged in recent years. However, the success rate for service of judicial documents under the Existing Arrangement is relatively low. In response to the strong demand from the legal sector, statutory bodies and members of the public for an enhanced service mechanism, the Department of Justice (DoJ), the Judiciary and the SPC, after an extended period of prudent discussions, finalised the enhanced mechanism for mutual service of judicial documents in civil and commercial proceedings between the Mainland and Hong Kong, with the New Arrangement signed yesterday. The New Arrangement aims to further promote the alignment of mechanisms and rules between the two legal systems.

The New Arrangement is not a completely new arrangement, but an enhanced version of the Existing Arrangement. The New Arrangement increases the modes of service, offers more options and flexibility, and introduces efficiency enhancement measures. This aims to promote timely and efficient handling of cross-border civil and commercial cases, strengthen the protection of the rights and interests of parties in the two places, and better accommodate the increasingly close-knit ties and judicial needs between the Mainland and Hong Kong.

The DoJ will introduce the New Arrangement to the Legislative Council Panel on Administration of Justice and Legal Services next Monday (April 27). The New Arrangement will come into effect only after the completion of relevant legislative procedures in Hong Kong. The DoJ will work closely with the Judiciary to complete the required legislative amendments work to implement the New Arrangement as soon as practicable.

Source: AI-found images